Current strategies in the management of intra-abdominal abscesses in crohn's disease

Linda A. Feagins, Stefan D. Holubar, Sunanda V. Kane, Stuart J. Spechler

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Crohn's disease is characterized by inflammation that involves the full thickness of the bowel wall, which can lead to serious complications including intra-abdominal and pelvic abscesses. The combination of an intra-abdominal abscess with active Crohn's disease poses a particular dilemma for the treating physician, who must weigh the benefits of using immunosuppressive therapies for the inflammatory bowel disease against the risks of immunosuppression in the presence of serious abdominal infection. Traditionally, Crohn's-related abscesses were managed with early surgery, which often involved external drainage procedures, bowel resection, and the creation of diverting ostomies in acutely ill patients. Today such abscesses often can be managed initially with antibiotics and percutaneous drainage, with evaluation for the need for delayed surgery in selected patients. With delayed surgery performed electively, the surgeon frequently can resect the diseased bowel and create a primary anastomosis, thus avoiding emergency operations and multistage procedures. In highly selected cases, surgery might be avoided entirely. This report reviews the literature on the pathophysiology and management of intra-abdominal abscesses in Crohn's disease (including the roles of percutaneous drainage, immunosuppressive therapy, and surgery), and provides a suggested approach to the management of patients with this difficult problem.

Original languageEnglish (US)
Pages (from-to)842-850
Number of pages9
JournalClinical Gastroenterology and Hepatology
Volume9
Issue number10
DOIs
StatePublished - Oct 2011

Fingerprint

Abdominal Abscess
Crohn Disease
Drainage
Immunosuppressive Agents
Abscess
Ostomy
Inflammatory Bowel Diseases
Immunosuppression
Emergencies
Anti-Bacterial Agents
Inflammation
Physicians
Therapeutics
Infection

Keywords

  • Abscess
  • Crohn's Disease
  • Inflammatory Bowel Disease

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Current strategies in the management of intra-abdominal abscesses in crohn's disease. / Feagins, Linda A.; Holubar, Stefan D.; Kane, Sunanda V.; Spechler, Stuart J.

In: Clinical Gastroenterology and Hepatology, Vol. 9, No. 10, 10.2011, p. 842-850.

Research output: Contribution to journalArticle

Feagins, Linda A. ; Holubar, Stefan D. ; Kane, Sunanda V. ; Spechler, Stuart J. / Current strategies in the management of intra-abdominal abscesses in crohn's disease. In: Clinical Gastroenterology and Hepatology. 2011 ; Vol. 9, No. 10. pp. 842-850.
@article{08ce870174444c0ea055216f5b4d7441,
title = "Current strategies in the management of intra-abdominal abscesses in crohn's disease",
abstract = "Crohn's disease is characterized by inflammation that involves the full thickness of the bowel wall, which can lead to serious complications including intra-abdominal and pelvic abscesses. The combination of an intra-abdominal abscess with active Crohn's disease poses a particular dilemma for the treating physician, who must weigh the benefits of using immunosuppressive therapies for the inflammatory bowel disease against the risks of immunosuppression in the presence of serious abdominal infection. Traditionally, Crohn's-related abscesses were managed with early surgery, which often involved external drainage procedures, bowel resection, and the creation of diverting ostomies in acutely ill patients. Today such abscesses often can be managed initially with antibiotics and percutaneous drainage, with evaluation for the need for delayed surgery in selected patients. With delayed surgery performed electively, the surgeon frequently can resect the diseased bowel and create a primary anastomosis, thus avoiding emergency operations and multistage procedures. In highly selected cases, surgery might be avoided entirely. This report reviews the literature on the pathophysiology and management of intra-abdominal abscesses in Crohn's disease (including the roles of percutaneous drainage, immunosuppressive therapy, and surgery), and provides a suggested approach to the management of patients with this difficult problem.",
keywords = "Abscess, Crohn's Disease, Inflammatory Bowel Disease",
author = "Feagins, {Linda A.} and Holubar, {Stefan D.} and Kane, {Sunanda V.} and Spechler, {Stuart J.}",
year = "2011",
month = "10",
doi = "10.1016/j.cgh.2011.04.023",
language = "English (US)",
volume = "9",
pages = "842--850",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Current strategies in the management of intra-abdominal abscesses in crohn's disease

AU - Feagins, Linda A.

AU - Holubar, Stefan D.

AU - Kane, Sunanda V.

AU - Spechler, Stuart J.

PY - 2011/10

Y1 - 2011/10

N2 - Crohn's disease is characterized by inflammation that involves the full thickness of the bowel wall, which can lead to serious complications including intra-abdominal and pelvic abscesses. The combination of an intra-abdominal abscess with active Crohn's disease poses a particular dilemma for the treating physician, who must weigh the benefits of using immunosuppressive therapies for the inflammatory bowel disease against the risks of immunosuppression in the presence of serious abdominal infection. Traditionally, Crohn's-related abscesses were managed with early surgery, which often involved external drainage procedures, bowel resection, and the creation of diverting ostomies in acutely ill patients. Today such abscesses often can be managed initially with antibiotics and percutaneous drainage, with evaluation for the need for delayed surgery in selected patients. With delayed surgery performed electively, the surgeon frequently can resect the diseased bowel and create a primary anastomosis, thus avoiding emergency operations and multistage procedures. In highly selected cases, surgery might be avoided entirely. This report reviews the literature on the pathophysiology and management of intra-abdominal abscesses in Crohn's disease (including the roles of percutaneous drainage, immunosuppressive therapy, and surgery), and provides a suggested approach to the management of patients with this difficult problem.

AB - Crohn's disease is characterized by inflammation that involves the full thickness of the bowel wall, which can lead to serious complications including intra-abdominal and pelvic abscesses. The combination of an intra-abdominal abscess with active Crohn's disease poses a particular dilemma for the treating physician, who must weigh the benefits of using immunosuppressive therapies for the inflammatory bowel disease against the risks of immunosuppression in the presence of serious abdominal infection. Traditionally, Crohn's-related abscesses were managed with early surgery, which often involved external drainage procedures, bowel resection, and the creation of diverting ostomies in acutely ill patients. Today such abscesses often can be managed initially with antibiotics and percutaneous drainage, with evaluation for the need for delayed surgery in selected patients. With delayed surgery performed electively, the surgeon frequently can resect the diseased bowel and create a primary anastomosis, thus avoiding emergency operations and multistage procedures. In highly selected cases, surgery might be avoided entirely. This report reviews the literature on the pathophysiology and management of intra-abdominal abscesses in Crohn's disease (including the roles of percutaneous drainage, immunosuppressive therapy, and surgery), and provides a suggested approach to the management of patients with this difficult problem.

KW - Abscess

KW - Crohn's Disease

KW - Inflammatory Bowel Disease

UR - http://www.scopus.com/inward/record.url?scp=80053132799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053132799&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2011.04.023

DO - 10.1016/j.cgh.2011.04.023

M3 - Article

C2 - 21679776

AN - SCOPUS:80053132799

VL - 9

SP - 842

EP - 850

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 10

ER -